|
Volumn 357, Issue 9257, 2001, Pages 691-
|
US company's plan for trial in Latin America draws fire.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DEVELOPING COUNTRY;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INTERNATIONAL COOPERATION;
MEDICAL ETHICS;
METHODOLOGY;
NEONATAL RESPIRATORY DISTRESS SYNDROME;
NEWBORN;
RANDOMIZED CONTROLLED TRIAL;
SOUTH AND CENTRAL AMERICA;
STANDARD;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
DEVELOPING COUNTRIES;
DRUG APPROVAL;
ETHICS, MEDICAL;
HUMANS;
INFANT, NEWBORN;
INTERNATIONALITY;
LATIN AMERICA;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
RESPIRATORY DISTRESS SYNDROME, NEWBORN;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0035799224
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(00)04145-3 Document Type: Article |
Times cited : (6)
|
References (0)
|